NervGen Pharma Corp. Common stock (NGEN) vs Neuronetics, Inc. (STIM)
A side-by-side comparison of NervGen Pharma Corp. Common stock and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NGEN
NervGen Pharma Corp. Common stock
$1.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STIM
Neuronetics, Inc.
$2.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NGEN vs STIM
growth of $100 · dividends reinvested · last 1yNGEN -57.6% (-57.6%/yr)STIM +70.5% (+70.5%/yr)STIM compounded faster over this window
NGEN STIM
NGEN vs STIM: by the numbers
- •STIM is the larger company ($154M vs $144M market cap).
- •Both run net losses; NGEN's is the smaller (0.00% vs -19.62% net margin).
Metrics side by side
Valuation
| Metric | NGEN | STIM |
|---|---|---|
| P/S ratio | N/A | 0.99 |
| P/B ratio | 11.81 | 8.62 |
Profitability
| Metric | NGEN | STIM |
|---|---|---|
| Gross margin | 0.00% | 49.12% |
| Operating margin | 0.00% | -14.74% |
| Net margin | 0.00% | -19.62% |
| ROE | -397.38% | -170.49% |
| ROIC | -223.90% | -22.15% |
Growth (annualized)
| Metric | NGEN | STIM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.26% |
| Total return CAGR (5Y) | N/A | -19.46% |
Go deeper
Dig into the metrics
NervGen Pharma Corp. Common stock ROENeuronetics ROENervGen Pharma Corp. Common stock operating marginNeuronetics operating marginNervGen Pharma Corp. Common stock revenue growthNeuronetics revenue growthNervGen Pharma Corp. Common stock free cash flowNeuronetics free cash flow
NervGen Pharma Corp. Common stock & Neuronetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.